比利时生物科技公司Galapagos NV(GLPG)今日盘前大跌5.04%,报收36.4欧元。此前,Galapagos公司公布了截至9月30日的最新季度财报,业绩数据低于市场预期,这被视为导致公司股价下跌的主要原因。
财报显示,Galapagos本季度调整后每股亏损77美分,而分析师此前平均预期为亏损49美分。公司本季度营收同比下降50.1%至5985万欧元,也低于分析师预期的6944万欧元。
同时,过去三个月来,分析师对Galapagos未来盈利的平均预测下降了约155.7%,显示外界对公司前景信心不足。虽然目前分析师对该股的一致评级为"持有",但显然该公司最新季度业绩疲软以及前景不佳预期令投资者对该股失去信心,进而导致股价在今日盘前重挫。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.